Home Infusion Therapy Market Size Report 2019 - 2026, Sales Volume, Revenue, Share, Growth Trend and Estimation Forecast

By Product (Infusion Pump, Intravenous Sets, IV Cannulas, Needleless Connectors), By Application (Anti-infective, Hydration Therapy, Chemotherapy, Enteral Nutrition, Parenteral Nutrition, Specialty Pharmaceuticals), Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, UK, France, Italy, Spain, China, India, Japan, South Korea, Australia, Brazil, Mexico, South Africa)
 

LATEST: This report includes COVID 19 Impact Analysis of the Market

  • Report ID : MD1432
  • |
  • Pages : 240
  • |
  • Tables : 85
  • |
  • Formats :

Home Infusion Therapy Market revenue is estimated to be $XX Billion in 2019 and shall grow with a CAGR of XX.X% during the forecast period of 2019 to 2026.
 

Home Infusion Therapy is a process whereby patients are administered medication via a needle or a catheter from a medical kit that works from the comfort of one’s home. This mode of introduction of the medication becomes necessary in diseases that respond to conventional methods such as syrups & tablets.
 
Analysis by Product
According to the product, the main segments are Infusion Pump, Intravenous Sets, IV Cannulas, and Needleless Connectors.
 
Intravenous sets will grow considerably over the projected timeframe. It is already a Multi-million dollar segment because of advantages such as extended action and monitored degree of administration. It also has safety features inbuilt to assist the end-user with the usage. One such benefit is the reduction of needle-handling injuries.
 
The intravenous cannulas segment is poised for nearly double-digit growth rates. It appeals to a wider array of implementation such as blood collection and dynamic monitoring of administered dosage. Cannula is also found in the manufacture of needles and results in the vital reach that the product needs to become effective. It is this niche application that will result in the product gaining momentum in sales in the forecasted period.
 
Analysis by Application
According to the application, the segments are Anti-infective, Hydration Therapy, Chemotherapy, Enteral Nutrition, Parenteral Nutrition, and Specialty Pharmaceuticals.
 
Parenteral Nutrition segment is anticipated to grow at an impressive rate in this period. The main demand-pull is arising out of developed nations as the need for home healthcare takes a turn for expansion. Additionally, the number of geriatric patients is increasing and Home Infusion Therapies will become a necessity rather than a choice. This is an excellent proposition for the companies in this industry.
 
The Hydration therapy segment is picking up pace at a healthy rate as well. It is closing in on the half a billion-dollar mark. It eases the administration of essential additives & electrolytes for the patients without the hassle of hospitalization. Besides, advancements in this field are active to make the patients self-sufficient. This will further drive the product adoption by the masses. 
  
Analysis by Region 
North America is a rapidly growing market for Home Infusion Therapies. The rising patient population coupled with relatively expensive hospital care is augmenting the drive for this product among the consumers. Innovations in this field are bridging the gap between the expertise available at full-service hospitals and home infusion therapies.
 
The Asia-Pacific region will witness double-digit growth rates in the upcoming future. This region has a mix of elderly people with gradually increasing disposable incomes. Comfort and convenience in the treatment of ailments is fast becoming a deciding factor for the choice of products among consumers. Thus, a few manufacturers are garnering some capital infusion to address the market needs in these geographies as well.
 
Analysis by Major Companies
Leading companies in this industry are CareFusion, Baxter, Fresenius Kabi, Smiths Medical, B. Braun, Caesarea Medical Electronics, Terumo and ICU Medical.
 
This industry is R&D intensive. It is a widely accepted fact that successful businesses in this space have to diligently inject capital at regular time intervals towards product innovation. This will match and exceed consumer expectations and add a level of comfort. Many times, it is the manufacturers that need to survey the market to catch its pulse and then form their research activities around those findings.
 
Nonetheless, the returns on investment for the shareholders in these companies are much higher than the performance of the stock market. This is, in part, since this product caters to a very sensitive consumer base.

COVERAGE HIGHLIGHTS    
●   Market Revenue Estimation and Forecast (2019 – 2026)
●   Market Production Estimation and Forecast (2019 – 2026)
●   Market Sales/Consumption Volume Estimation and Forecast (2019 – 2026)
●   Breakdown of Revenue by Segments (2019 – 2026)
●   Breakdown of Production by Segments (2019 – 2026)
●   Breakdown of Sales Volume by Segments (2019 – 2026)
●   Gross Margin and Profitability Analysis of Companies
●   Business Trend and Expansion Analysis
●   Import and Export Analysis
●   Regional Analysis and Market Data Breakdown
 

MARKET SEGMENTATION
 
By Product Outlook ($Revenue and Unit Sales, 2019-2026)
•    Infusion Pump
•    Intravenous Sets
•    IV Cannulas
•    Needleless Connectors


By Application Outlook ($Revenue and Unit Sales, 2019-2026)
•    Anti-infective
•    Hydration Therapy
•    Chemotherapy
•    Enteral Nutrition
•    Parenteral Nutrition
•    Specialty Pharmaceuticals


By Regional Outlook ($Revenue and Unit Sales, 2019-2026)
•    U.S.
•    Canada
•    Germany
•    UK
•    France
•    Italy
•    Spain
•    China
•    India
•    Japan
•    South Korea
•    Australia
•    Brazil
•    Mexico
•    South Africa
        

Major Companies
•    B. Braun Melsungen AG
•    Baxter International, Inc.
•    Caesarea Medical Electronics
•    CareFusion Corporation
•    Fresenius Kabi
•    ICU Medical Inc
•    JMS Co. Ltd.
•    Smiths Medical
•    Terumo Corporation

 

CHAPTER 1:    INTRODUCTION
 

1.1.    RESEARCH METHODOLOGY
1.1.1.    Desk Research 
1.1.2.    Data Synthesis 
1.1.3.    Data Validation & Market Feedback 
1.1.4.    Data Sources 

 

CHAPTER 2:    EXECUTIVE SUMMARY
2.1.    GLOBAL MARKET OUTLOOK
2.2.    CORE INSIGHTS –DELIVERY MODEL
2.3.    CORE INSIGHTS – HOME INFUSION THERAPY
2.4.    CORE INSIGHTS – SERVICE PROVIDER
2.5.    CORE INSIGHTS – GEOGRAPHY 

 

CHAPTER 3:   MARKET OVERVIEW
 

3.1.     MARKET DEFINITION AND SCOPE
 

3.2.    KEY FORCES SHAPING THE INDUSTRY
3.2.1.    Bargaining Power of Suppliers
3.2.2.    Bargaining Power of Buyers
3.2.3.    Threat of Substitutes
3.2.4.    Threat of New Entrants

 

3.3.    MARKET DYNAMICS
3.3.1.    Drivers
3.3.1.1.    Supply-side Drivers
3.3.1.2.    Demand-side Drivers
3.3.2.    Restraints
3.3.3.    Opportunities

 

3.4.    INDUSTRY - ANALYSIS
3.4.1.    Political Market
3.4.2.    Environmental Market
3.4.3.    Social Market
3.4.4.    Technology Market

 

CHAPTER 4:    MARKET BACKGROUND
 

4.1.    Industry Value Chain Analysis
4.1.1.    Upstream Participants 
4.1.2.    Downstream participants

 

4.2.    Pricing Analysis and Forecast, 2019-2026
4.2.1.    By Type
4.2.2.    By Region

 

CHAPTER 5:    HOME INFUSION THERAPY MARKET, BY PRODUCTION OUTLOOK
 

5.1.    Overview
5.1.1.    Market Revenue (US$ Million) and Forecast, 2019-2026

 

5.2.    Infusion Pump
5.2.1.    Key Market Trends, Growth Factors and Opportunities
5.2.2.    Market Revenue (US$ Million) and Forecast, By Region

 

5.3.    Intravenous Sets
5.3.1.    Key Market Trends, Growth Factors and Opportunities
5.3.2.    Market Revenue (US$ Million) and Forecast, By Region

 

5.4.     IV Cannulas
5.4.1.    Key Market Trends, Growth Factors and Opportunities
5.4.2.    Market Revenue (US$ Million) and Forecast, By Region

 

5.5.    Needleless Connectors
5.5.1.    Key Market Trends, Growth Factors and Opportunities
5.5.2.    Market Revenue (US$ Million) and Forecast, By Region

 

CHAPTER 6:    HOME INFUSION THERAPY MARKET BY APPLICATION OUTLOOK
 

6.1.    Overview
6.1.1.    Market Revenue (US$ Million) and Forecast, 2019-2026

 

6.2.    Anti-infective
6.2.1.    Key Market Trends, Growth Factors and Opportunities
6.2.2.    Market Revenue (US$ Million) and Forecast, By Region

 

6.3.    Hydration Therapy
6.3.1.    Key Market Trends, Growth Factors and Opportunities
6.3.2.    Market Revenue (US$ Million) and Forecast, By Region

 

6.4.    Chemotherapy
6.4.1.    Key Market Trends, Growth Factors and Opportunities
6.4.2.    Market Revenue (US$ Million) and Forecast, By Region

 

6.5.    Enteral Nutrition
6.5.1.    Key Market Trends, Growth Factors and Opportunities
6.5.2.    Market Revenue (US$ Million) and Forecast, By Region

 

6.6.    Parenteral Nutrition
6.6.1.    Key Market Trends, Growth Factors and Opportunities
6.6.2.    Market Revenue (US$ Million) and Forecast, By Region

 

6.7.    Specialty Pharmaceuticals
6.7.1.    Key Market Trends, Growth Factors and Opportunities
6.7.2.    Market Revenue (US$ Million) and Forecast, By Region

   
CHAPTER 7:    HOME INFUSION THERAPY MARKET, BY GEOGRAPHY

 

7.1.    Overview
 

7.2.    North America 
7.2.1.    Key Market Trends, Growth Factors and Opportunities
7.2.2.    Market Revenue and Forecast, By Delivery Model
7.2.3.    Market Revenue and Forecast, By Agriculture Type
7.2.4.    Market Revenue and Forecast, By Service Provider
7.2.5.    Market Revenue and Forecast, By Country
7.2.6.    U.S.
             7.2.6.1.    Market Revenue and Forecast
7.2.7.    Canada
            7.2.7.1.    Market Revenue and Forecast
7.2.8.    Mexico
            7.2.8.1.    Market Revenue and Forecast

 

7.3.    Europe
7.3.1.    Market Revenue and Forecast, By Delivery Model
7.3.2.    Market Revenue and Forecast, By Agriculture Type
7.3.3.    Market Revenue and Forecast, By Service Provider
7.3.4.    Market Revenue and Forecast, By Country
7.3.5.    Germany
             7.3.5.1.    Market Revenue and Forecast
7.3.6.    UK
             7.3.6.1.    Market Revenue and Forecast
7.3.7.    France
            7.3.7.1.    Market Revenue and Forecast
7.3.8.    Italy
             7.3.8.1.    Market Revenue and Forecast
7.3.9.    Spain
            7.3.9.1.    Market Revenue and Forecast
7.3.10.    Poland
              7.3.10.1.    Market Revenue and Forecast
7.3.11.    Austrai
              7.3.11.1.    Market Revenue and Forecast
7.3.12.    Luxembourg
              7.3.12.1.    Market Revenue and Forecast
7.3.13.    Rest of Europe
              7.3.13.1.    Market Revenue and Forecast

7.4.    Asia-Pacific
7.4.1.    Market Revenue and Forecast, By Delivery Model
7.4.2.    Market Revenue and Forecast, By Agriculture Type
7.4.3.    Market Revenue and Forecast, By Service Provider
7.4.4.    Market Revenue and Forecast, By Country
7.4.5.    China
             7.4.5.1.    Market Revenue and Forecast
7.4.6.    India
            7.4.6.1.    Market Revenue and Forecast
7.4.7.    Japan 
             7.4.7.1.    Market Revenue and Forecast
7.4.8.    South Korea 
            7.4.8.1.    Market Revenue and Forecast
7.4.9.    Rest of APAC
             7.4.9.1.    Market Revenue and Forecast

 

7.5.    REST OF THE WORLD
7.5.1.    Market Revenue and Forecast, By Delivery Model
7.5.2.    Market Revenue and Forecast, By Agriculture Type
7.5.3.    Market Revenue and Forecast, By Service Provider
7.5.4.    Market Revenue and Forecast, By Country
7.5.5.    Latin America 
             7.5.5.1.    Market Revenue and Forecast
7.5.6.    Middle East  
             7.5.6.1.    Market Revenue and Forecast
7.5.7.    Africa 
             7.5.7.1.    Market Revenue and Forecast

 

CHAPTER 8:    COMPETITIVE MARKET
 

8.1.    HOME INFUSION THERAPY Market  Share Analysis, 2019

CHAPTER 9:  COMPANY PROFILES
 

9.1.    Airbus S.A.S
9.1.1.    Company Overview 
9.1.2.    Financial Performance
9.1.3.    SWOT Analysis

 

9.2.    Aviation Industry Corporation of China Ltd. (AVIC)
9.2.1.    Company Overview 
9.2.2.    Financial Performance
9.2.3.    SWOT Analysis

 

9.3.    Astronics Corporation
9.3.1.    Company Overview 
9.3.2.    Financial Performance
9.3.3.    SWOT Analysis

 

9.4.    Boeing
9.4.1.    Company Overview 
9.4.2.    Financial Performance
9.4.3.    SWOT Analysis

 

9.5.    Ball Corporation
9.5.1.    Company Overview 
9.5.2.    Financial Performance
9.5.3.    SWOT Analysis

 

9.6.    BAE Systems
9.6.1.    Company Overview 
9.6.2.    Financial Performance
9.6.3.    SWOT Analysis

 

9.7.    Cobham plc
9.7.1.    Company Overview 
9.7.2.    Financial Performance
9.7.3.    SWOT Analysis

 

9.8.    Curtiss Wright
9.8.1.    Company Overview 
9.8.2.    Financial Performance
9.8.3.    SWOT Analysis

 

9.9.    Elbit System
9.9.1.    Company Overview 
9.9.2.    Financial Performance
9.9.3.    SWOT Analysis

 

9.10.    Gramin Ltd
9.10.1.    Company Overview 
9.10.2.    Financial Performance
9.10.3.    SWOT Analysis

 

9.11.    GE Aviation
9.11.1.    Company Overview 
9.11.2.    Financial Performance
9.11.3.    SWOT Analysis

 

9.12.    Harris Corporation
9.12.1.    Company Overview 
9.12.2.    Financial Performance
9.12.3.    SWOT Analysis

 

9.13.    Honeywell International Inc.
9.13.1.    Company Overview 
9.13.2.    Financial Performance
9.13.3.    SWOT Analysis

 

9.14.    Lockheed Martin Corporation
9.14.1.    Company Overview 
9.14.2.    Financial Performance
9.14.3.    SWOT Analysis

 

9.15.    L3 Harris Corporation
9.15.1.    Company Overview 
9.15.2.    Financial Performance
9.15.3.    SWOT Analysis

 

9.16.    Meggitt PLC
9.16.1.    Company Overview 
9.16.2.    Financial Performance
9.16.3.    SWOT Analysis

 

9.17.    Northrop Grumman Corporation
9.17.1.    Company Overview 
9.17.2.    Financial Performance
9.17.3.    SWOT Analysis

 

9.18.    Nucon Aerospace
9.18.1.    Company Overview 
9.18.2.    Financial Performance
9.18.3.    SWOT Analysis

 

9.19.    Panasonic Corporation
9.19.1.    Company Overview 
9.19.2.    Financial Performance
9.19.3.    SWOT Analysis

 

9.20.    Rolls Royce
9.20.1.    Company Overview 
9.20.2.    Financial Performance
9.20.3.    SWOT Analysis

 

9.21.    Raytheon Company
9.21.1.    Company Overview 
9.21.2.    Financial Performance
9.21.3.    SWOT Analysis

 

9.22.    Saab AB
9.22.1.    Company Overview 
9.22.2.    Financial Performance
9.22.3.    SWOT Analysis

 

9.23.    Safran
9.23.1.    Company Overview 
9.23.2.    Financial Performance
9.23.3.    SWOT Analysis

 

9.24.    Thales Group
9.24.1.    Company Overview 
9.24.2.    Financial Performance
9.24.3.    SWOT Analysis

 

9.25.    Teledyne Technologies Inc.
9.25.1.    Company Overview 
9.25.2.    Financial Performance
9.25.3.    SWOT Analysis

 

9.26.    Transdigm Group Inc.
9.26.1.    Company Overview 
9.26.2.    Financial Performance
9.26.3.    SWOT Analysis

PURCHASE OPTIONS

20% Free Customization ON ALL PURCHASE

*Terms & Conditions Apply

Request Free Sample

Please fill in the form below to Request for free Sample Report

  • Office Hours Mon - Sat   10:00 - 16:00

  • Send Us Mail sales@marketdecipher.com